2026-2034年全球人乳寡糖（HMO）市场规模、份额、趋势和成长分析报告

预计人乳低聚醣 (HMO) 市场将从 2025 年的 4.1349 亿美元成长到 2034 年的 27.2748 亿美元，2026 年至 2034 年的复合年增长率为 23.32%。

由于对先进婴幼儿营养解决方案的需求不断增长，全球母乳寡糖 (HMO) 市场正快速成长。 HMO 是一种生物活性碳水化合物，能够支持婴幼儿的免疫系统发育和肠道健康。意识提升，是推动市场成长的主要因素。

关键成长要素包括婴儿奶粉产量增加、基于生物技术的HMO合成技术步骤以及肠道菌丛健康研究的进展。製造商正将HMO添加到高端婴儿营养产品中，以模拟母乳的益处。各地监管部门的核准也推动了其商业化进程。

展望未来，随着新型HMO研究的深入以及其在众多健康领域的应用拓展，市场预计将持续扩张。在新兴市场，由于出生率和可支配收入的增加，预计市场需求将强劲增长。大规模生产技术的创新将提升产品的价格竞争力。随着婴幼儿营养标准的不断完善，HMO市场可望维持持续成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球人乳低聚醣（HMO）市场：按类型划分

• 市场分析、洞察与预测
• 2'FL
• 3'FL
• 3'SL
• 6'SL

第五章：全球人乳寡糖（HMO）市场：依应用领域划分

• 市场分析、洞察与预测
• 婴儿奶粉
• 功能性食品和饮料
• 食品补充剂
• 其他用途
• 其他的

第六章：全球人乳寡糖（HMO）市场：依浓度划分

• 市场分析、洞察与预测
• 中性的
• 酸性

第七章 全球人乳寡糖（HMO）市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • DSM
  • BASF SE
  • CHR Hansen Holding A/S
  • DuPont
  • NestlAfA（C）
  • Biosynth Carbosynth
  • Inbiose NV
  • Gnubiotics Sciences SA
  • Abbott Laboratories
  • Royal Friesland Campina NV
  • Elicityl SA
  • Dextra Laboratories

The Human Milk Oligosaccharides (HMO) Market size is expected to reach USD 2727.48 Million in 2034 from USD 413.49 Million (2025) growing at a CAGR of 23.32% during 2026-2034.

The Global Human Milk Oligosaccharides (HMO) Market has grown rapidly due to increasing demand for advanced infant nutrition solutions. HMOs are bioactive carbohydrates that support immune development and gut health in infants. Rising awareness among parents about scientifically formulated infant products has significantly driven market growth.

Key growth drivers include expanding infant formula production, technological advancements in biotechnology-based HMO synthesis, and growing research on gut microbiome health. Manufacturers are incorporating HMOs into premium infant nutrition products to replicate the benefits of human breast milk. Regulatory approvals in various regions further support commercialization.

Looking ahead, the market is expected to expand with continued research into additional HMO types and broader health applications. Emerging markets are anticipated to generate strong demand due to rising birth rates and disposable incomes. Innovation in large-scale production technologies will enhance affordability. As infant nutrition standards evolve, the HMO market is projected to experience sustained growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• 2' FL
• 3' FL
• 3' SL
• 6' SL

By Application

• Infant Formula
• Functional Food & Beverages
• Food Supplements
• Other Applications
• Other

By Concentration

• Neutral
• Acidic

COMPANIES PROFILED

• DSM, BASF SE, CHR Hansen Holding AS, DuPont, Nestl, Biosynth Carbosynth, Inbiose NV, Gnubiotics Sciences SA, Abbott Laboratories, Royal Friesland Campina NV, Elicityl SA, Dextra Laboratories

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET: BY TYPE 2022-2034 (USD MN and Kilo Tons)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. 2' FL Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 4.3. 3' FL Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 4.4. 3' SL Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 4.5. 6' SL Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)

Chapter 5. GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET: BY APPLICATION 2022-2034 (USD MN and Kilo Tons)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Infant Formula Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 5.3. Functional Food & Beverages Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 5.4. Food Supplements Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 5.5. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 5.6. Other Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)

Chapter 6. GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET: BY CONCENTRATION 2022-2034 (USD MN and Kilo Tons)

• 6.1. Market Analysis, Insights and Forecast Concentration
• 6.2. Neutral Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 6.3. Acidic Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)

Chapter 7. GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET: BY REGION 2022-2034(USD MN and Kilo Tons)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 7.2.1 By Type
  • 7.2.2 By Application
  • 7.2.3 By Concentration
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 7.3.1 By Type
  • 7.3.2 By Application
  • 7.3.3 By Concentration
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 7.4.1 By Type
  • 7.4.2 By Application
  • 7.4.3 By Concentration
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 7.5.1 By Type
  • 7.5.2 By Application
  • 7.5.3 By Concentration
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 7.6.1 By Type
  • 7.6.2 By Application
  • 7.6.3 By Concentration
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 DSM
  • 9.2.2 BASF SE
  • 9.2.3 CHR Hansen Holding A/S
  • 9.2.4 DuPont
  • 9.2.5 NestlAfA(C)
  • 9.2.6 Biosynth Carbosynth
  • 9.2.7 Inbiose N.V
  • 9.2.8 Gnubiotics Sciences S.A
  • 9.2.9 Abbott Laboratories
  • 9.2.10 Royal Friesland Campina N.V
  • 9.2.11 Elicityl S.A
  • 9.2.12 Dextra Laboratories